B. Ljungberg, S. Campbell, H. Choi, D. Jacqmin, J. Lee et al., The Epidemiology of Renal Cell Carcinoma, European Urology, vol.60, issue.4, pp.615-636, 2011.
DOI : 10.1016/j.eururo.2011.06.049

G. Decastro and J. Mckiernan, Epidemiology, clinical staging, and presentation of renal cell carcinoma. The Urologic clinics of North America, pp.581-92, 2008.

L. Lipworth, R. Tarone, and J. Mclaughlin, The Epidemiology of Renal Cell Carcinoma, The Journal of Urology, vol.176, issue.6, pp.2353-2361, 2006.
DOI : 10.1016/j.juro.2006.07.130

J. Mclaughlin, L. Lipworth, and R. Tarone, Epidemiologic Aspects of Renal Cell Carcinoma, Seminars in Oncology, vol.33, issue.5, pp.527-560, 2006.
DOI : 10.1053/j.seminoncol.2006.06.010

F. Algaba, H. Akaza, A. Lopez-beltran, G. Martignoni, H. Moch et al., Current Pathology Keys of Renal Cell Carcinoma, European Urology, vol.60, issue.4, pp.634-677, 2011.
DOI : 10.1016/j.eururo.2011.06.047

A. Bradley, Y. Lim, and F. Singh, Imaging features, follow-up, and management of incidentally detected renal lesions, Clinical Radiology, vol.66, issue.12, pp.1129-1168, 2011.
DOI : 10.1016/j.crad.2011.07.044

K. Gupta, J. Miller, J. Li, M. Russell, and C. Charbonneau, Epidemiologic and socioeconomic burden of metastatic renal cell carcinoma (mRCC): A literature review, Cancer Treatment Reviews, vol.34, issue.3, pp.193-205, 2008.
DOI : 10.1016/j.ctrv.2007.12.001

A. Mejean and T. Lebret, Prise en charge of metastatic renal carcinoma] Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie, 2008.

H. Moch, W. Artibani, B. Delahunt, V. Ficarra, R. Knuechel et al., Reassessing the Current UICC/AJCC TNM Staging for Renal Cell Carcinoma, European Urology, vol.56, issue.4, pp.636-679, 2009.
DOI : 10.1016/j.eururo.2009.06.036

URL : https://hal.archives-ouvertes.fr/inserm-00406314

S. Kim, A. Alt, C. Weight, B. Costello, J. Cheville et al., Independent Validation of the 2010 American Joint Committee on Cancer TNM Classification for Renal Cell Carcinoma: Results From a Large, Single Institution Cohort, The Journal of Urology, vol.185, issue.6, pp.2035-2044, 2011.
DOI : 10.1016/j.juro.2011.02.059

S. Eggener, TNM Staging for Renal Cell Carcinoma: Time for a New Method, European Urology, vol.58, issue.4, pp.517-526, 2010.
DOI : 10.1016/j.eururo.2010.08.007

C. Maurin, Kidney cancer treatments Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie, pp.799-801, 2010.

J. Patard, H. Baumert, J. Correas, B. Escudier, H. Lang et al., Recommendations Onco-Urology 2010: Kidney cancer Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie, pp.319-358, 2010.

B. Ljungberg, N. Cowan, D. Hanbury, M. Hora, M. Kuczyk et al., EAU Guidelines on Renal Cell Carcinoma: The 2010 Update, European Urology, vol.58, issue.3, pp.398-406, 2010.
DOI : 10.1016/j.eururo.2010.06.032

URL : https://hal.archives-ouvertes.fr/inserm-00511115

A. Volpe, J. Cadeddu, A. Cestari, I. Gill, M. Jewett et al., Contemporary Management of Small Renal Masses, European Urology, vol.60, issue.3, pp.501-516, 2011.
DOI : 10.1016/j.eururo.2011.05.044

C. Maurin, F. Vidal, and E. Lechevallier, What is the role of active surveillance for small renal masses? Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie, pp.895-900, 2011.

C. Beisland, K. Hjelle, L. Reisaeter, and L. Bostad, Observation Should be Considered as an Alternative in Management of Renal Masses in Older and Comorbid Patients, European Urology, vol.55, issue.6, pp.1419-1446, 2009.
DOI : 10.1016/j.eururo.2008.12.031

F. Audenet, M. Roupret, and A. Mejean, [Renal cell carcinoma and antiangiogenic agents: ongoing controversies are seeking answers for improvement of therapeutic management

S. Waalkes, M. Kramer, T. Herrmann, A. Schrader, M. Kuczyk et al., Present state of target therapy for disseminated renal cell carcinoma, Immunotherapy, vol.2, issue.3, pp.393-401, 2010.
DOI : 10.2217/imt.10.14

T. De-reijke, J. Bellmunt, H. Van-poppel, S. Marreaud, and M. Aapro, EORTC-GU group expert opinion on metastatic renal cell cancer, European Journal of Cancer, vol.45, issue.5, pp.765-73, 2009.
DOI : 10.1016/j.ejca.2008.12.010

U. Patel and H. Sokhi, Imaging in the Follow-Up of Renal Cell Carcinoma, American Journal of Roentgenology, vol.198, issue.6, pp.1266-76, 2012.
DOI : 10.2214/AJR.11.8381

A. Skolarikos, G. Alivizatos, P. Laguna, and J. De-la-rosette, A Review on Follow-Up Strategies for Renal Cell Carcinoma after Nephrectomy, European Urology, vol.51, issue.6, pp.1490-500, 2007.
DOI : 10.1016/j.eururo.2006.12.031

J. Verine, A. Pluvinage, G. Bousquet, J. Lehmann-che, C. De-bazelaire et al., Hereditary Renal Cancer Syndromes: An Update of a Systematic Review, European Urology, vol.58, issue.5, pp.701-711, 2010.
DOI : 10.1016/j.eururo.2010.08.031

B. Shuch, E. Singer, and G. Bratslavsky, The surgical approach to multifocal renal cancers: hereditary syndromes, ipsilateral multifocality, and bilateral tumors. The Urologic clinics of North America, pp.133-181, 2012.

Y. Neuzillet, E. Lechevallier, M. Andre, L. Daniel, and C. Coulange, Accuracy and Clinical Role of Fine Needle Percutaneous Biopsy With Computerized Tomography Guidance of Small (Less Than 4.0 Cm) Renal Masses, The Journal of Urology, vol.171, issue.5, pp.1802-1807, 2004.
DOI : 10.1097/01.ju.0000120147.51090.2b

C. Thuillier, J. Long, O. Lapouge, D. Pasquier, N. Terrier et al., Value of percutaneous biopsy for solid renal tumours less than 4 cm in diameter based on a series of 53 cases. Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie, pp.435-444, 2008.

M. Remzi and M. Marberger, Renal tumor biopsies for evaluation of small renal tumors: why, in whom, and how? European urology, pp.359-67, 2009.

S. Pahernik, F. Roos, B. Rohrig, C. Wiesner, and J. Thuroff, Elective Nephron Sparing Surgery for Renal Cell Carcinoma Larger Than 4 cm, The Journal of Urology, vol.179, issue.1, pp.71-75, 2008.
DOI : 10.1016/j.juro.2007.08.165

H. Van-poppel, D. Pozzo, L. Albrecht, W. Matveev, V. Bono et al., A Prospective, Randomised EORTC Intergroup Phase 3 Study Comparing the Oncologic Outcome of Elective Nephron-Sparing Surgery and Radical Nephrectomy for Low-Stage Renal Cell Carcinoma, European Urology, vol.59, issue.4, pp.543-52, 2011.
DOI : 10.1016/j.eururo.2010.12.013

A. Antonelli, A. Cozzoli, M. Nicolai, D. Zani, T. Zanotelli et al., Nephron-Sparing Surgery versus Radical Nephrectomy in the Treatment of Intracapsular Renal Cell Carcinoma up to 7cm, European Urology, vol.53, issue.4, pp.803-812, 2008.
DOI : 10.1016/j.eururo.2007.11.007

D. Kunkle, B. Egleston, and R. Uzzo, Excise, Ablate or Observe: The Small Renal Mass Dilemma???A Meta-Analysis and Review, The Journal of Urology, vol.179, issue.4, pp.1227-1260, 2008.
DOI : 10.1016/j.juro.2007.11.047

R. Thompson, J. Hill, Y. Babayev, A. Cronin, M. Kaag et al., Metastatic Renal Cell Carcinoma Risk According to Tumor Size, The Journal of Urology, vol.182, issue.1, pp.41-46, 2009.
DOI : 10.1016/j.juro.2009.02.128

F. Arroua, C. Maurin, A. Carcenac, E. Ragni, D. Rossi et al., Role of surgery (cytoreductive nephrectomy and metastasectomy) in the management of metastatic renal cell carcinoma: a literature review Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie, pp.1175-83, 2010.

P. Russo, Multi-modal treatment for metastatic renal cancer: the role of surgery, World Journal of Urology, vol.53, issue.3, pp.295-301, 2010.
DOI : 10.1007/s00345-010-0530-x

P. Russo, O. Brien, and M. , Surgical intervention in patients with metastatic renal cancer: metastasectomy and cytoreductive nephrectomy. The Urologic clinics of North America, pp.679-86, 2008.

S. Oudard, J. Cornu, M. Roupret, and J. Patard, Antiangiogenic treatment and kidney cancer: ongoing trials and future perspectives] Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie, pp.77-80, 2008.

T. Hutson, Targeted Therapies for the Treatment of Metastatic Renal Cell Carcinoma: Clinical Evidence, The Oncologist, vol.16, issue.Supplement 2, pp.14-22, 2011.
DOI : 10.1634/theoncologist.2011-S2-14

V. Margulis, V. Master, N. Cost, B. Leibovich, S. Joniau et al., International Consultation on Urologic Diseases and the European Association of Urology International Consultation on Locally Advanced Renal Cell Carcinoma, European Urology, vol.60, issue.4, pp.673-83, 2011.
DOI : 10.1016/j.eururo.2011.06.042

J. Descotes, Open partial nephrectomy techniques for cancer of the kidney Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie, pp.234-241, 2009.

J. Descotes and J. Doublet, Renal imaging and biopsy for diagnosis of renal masses, Annales d'Urologie, vol.40
DOI : 10.1016/S0003-4401(06)80030-6

. Progres-en-urologie, Association francaise d'urologie et de la Societe francaise d'urologie, pp.1101-1145, 2007.

D. Pascual and A. Borque, Epidemiology of kidney cancer Advances in urology, p.782381, 2008.

X. Taccoen, A. Valeri, J. Descotes, V. Morin, E. Stindel et al., Renal Cell Carcinoma in Adults 40 Years Old or Less: Young Age is an Independent Prognostic Factor for Cancer-Specific Survival, European Urology, vol.51, issue.4, pp.980-987, 2007.
DOI : 10.1016/j.eururo.2006.10.025

D. Chambade, P. Meria, E. Tariel, J. Verine, D. Kerviler et al., Nephron Sparing Surgery is a Feasible and Efficient Treatment of T1a Renal Cell Carcinoma in Kidney Transplant: A Prospective Series From a Single Center, The Journal of Urology, vol.180, issue.5, pp.2106-2115, 2008.
DOI : 10.1016/j.juro.2008.07.055

R. Thompson, J. Kurta, M. Kaag, S. Tickoo, S. Kundu et al., Tumor Size is Associated With Malignant Potential in Renal Cell Carcinoma Cases, The Journal of Urology, vol.181, issue.5, pp.2033-2039, 2009.
DOI : 10.1016/j.juro.2009.01.027

H. Palsdottir, S. Hardarson, V. Petursdottir, A. Jonsson, E. Jonsson et al., Incidental Detection of Renal Cell Carcinoma is an Independent Prognostic Marker: Results of a Long-Term, Whole Population Study, The Journal of Urology, vol.187, issue.1, pp.48-53, 2012.
DOI : 10.1016/j.juro.2011.09.025

E. Comperat, V. Vasiliu, S. Ferlicot, P. Camparo, M. Sibony et al., Tumeurs du rein : les nouvelles entit??s, Annales de Pathologie, vol.25, issue.2, pp.117-150, 2005.
DOI : 10.1016/S0242-6498(05)86175-9

A. Pantuck, A. Zisman, and A. Belldegrun, THE CHANGING NATURAL HISTORY OF RENAL CELL CARCINOMA, The Journal of Urology, vol.166, issue.5, pp.1611-1634, 2001.
DOI : 10.1016/S0022-5347(05)65640-6

G. Mickisch, J. Carballido, S. Hellsten, H. Schulze, and H. Mensink, Guidelines on Renal Cell Cancer, European Urology, vol.40, issue.3, pp.252-257, 2001.
DOI : 10.1159/000049783

M. Aron and I. Gill, Minimally invasive nephron-sparing surgery (MINSS) for renal tumours

D. Miller, J. Ruterbusch, J. Colt, F. Davis, W. Linehan et al., Contemporary Clinical Epidemiology of Renal Cell Carcinoma: Insight From a Population Based Case-Control Study, The Journal of Urology, vol.184, issue.6, pp.2254-2262, 2010.
DOI : 10.1016/j.juro.2010.08.018

L. Lund, J. Jacobsen, M. Norgaard, J. Mclaughlin, W. Blot et al., The prognostic impact of comorbidities on renal cancer: a Danish population based study Prognostic factors for renal cell carcinoma. Cancer treatment reviews, The Journal of urology, vol.18234, pp.35-40407, 1995.

D. Berger, I. Megwalu, A. Vlahiotis, M. Radwan, M. Serrano et al., Impact of Comorbidity on Overall Survival in Patients Surgically Treated for Renal Cell Carcinoma, Urology, vol.72, issue.2, pp.359-63, 2008.
DOI : 10.1016/j.urology.2008.02.061

K. Touijer, D. Jacqmin, L. Kavoussi, F. Montorsi, J. Patard et al., The Expanding Role of Partial Nephrectomy: A Critical Analysis of Indications, Results, and Complications, European Urology, vol.57, issue.2, pp.214-236, 2010.
DOI : 10.1016/j.eururo.2009.10.019

URL : https://hal.archives-ouvertes.fr/inserm-00434424

F. Cornelis, P. Balageas, L. Bras, Y. Rigou, G. Boutault et al., Radiologically-guided thermal ablation of renal tumours. Diagnostic and interventional imaging, pp.246-61, 2012.

J. Long, Y. Neuzillet, L. Poissonnier, H. Lang, P. Paparel et al., Do ablative treatments modify the management of kidney tumors in the elderly?]. Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie, 2009.

M. Aron and I. Gill, Minimally Invasive Nephron-Sparing Surgery (MINSS) for Renal Tumours, European Urology, vol.51, issue.2, pp.337-383, 2007.
DOI : 10.1016/j.eururo.2006.10.018

A. Belot, P. Grosclaude, N. Bossard, E. Jougla, E. Benhamou et al., Cancer incidence and mortality in France over the period 1980-2005. Revue d'epidemiologie et de sante publique, pp.159-75, 2008.
URL : https://hal.archives-ouvertes.fr/hal-00538673

S. Campbell, A. Novick, A. Belldegrun, M. Blute, G. Chow et al., Guideline for Management of the Clinical T1 Renal Mass, The Journal of Urology, vol.182, issue.4, pp.1271-1280, 2009.
DOI : 10.1016/j.juro.2009.07.004

A. Kutikov, R. Uzzo, and R. E. The, The R.E.N.A.L. Nephrometry Score: A Comprehensive Standardized System for Quantitating Renal Tumor Size, Location and Depth, The Journal of Urology, vol.182, issue.3, pp.844-53, 2009.
DOI : 10.1016/j.juro.2009.05.035

V. Ficarra, G. Novara, S. Secco, V. Macchi, A. Porzionato et al., Preoperative Aspects and Dimensions Used for an Anatomical (PADUA) Classification of Renal Tumours in Patients who are Candidates for Nephron-Sparing Surgery, European Urology, vol.56, issue.5, pp.786-93, 2009.
DOI : 10.1016/j.eururo.2009.07.040

M. Hayn, T. Schwaab, W. Underwood, and H. Kim, RENAL nephrometry score predicts surgical outcomes of laparoscopic partial nephrectomy, BJU International, vol.56, pp.876-81
DOI : 10.1111/j.1464-410X.2010.09940.x

S. Montag, N. Waingankar, M. Sadek, S. Rais-bahrami, L. Kavoussi et al., Reproducibility and Fidelity of the R.E.N.A.L. Nephrometry Score, Journal of Endourology, vol.25, issue.12, pp.1925-1933
DOI : 10.1089/end.2011.0217

A. Mottrie, P. Schatteman, D. Wil, P. , D. Troyer et al., Validation of the preoperative aspects and dimensions used for an anatomical (PADUA) score in a robotassisted partial nephrectomy series, World journal of urology

S. Tyritzis, S. Papadoukakis, I. Katafigiotis, I. Adamakis, I. Anastasiou et al., Implementation and external validation of Preoperative Aspects and Dimensions Used for an Anatomical (PADUA) score for predicting complications in 74 consecutive partial nephrectomies, BJU International, vol.184, issue.12
DOI : 10.1111/j.1464-410X.2011.10644.x

D. Dindo, N. Demartines, and P. Clavien, Classification of Surgical Complications, Annals of Surgery, vol.240, issue.2, pp.205-218, 2004.
DOI : 10.1097/01.sla.0000133083.54934.ae

B. Lane, I. Gill, A. Fergany, B. Larson, and S. Campbell, Limited Warm Ischemia During Elective Partial Nephrectomy has Only a Marginal Impact on Renal Functional Outcomes, The Journal of Urology, vol.185, issue.5, pp.1598-603
DOI : 10.1016/j.juro.2010.12.046

S. Hallan, A. Asberg, M. Lindberg, and H. Johnsen, Validation of the modification of diet in renal disease formula for estimating GFR with special emphasis on calibration of the serum creatinine assay, American Journal of Kidney Diseases, vol.44, issue.1, pp.84-93, 2004.
DOI : 10.1053/j.ajkd.2004.03.027

J. Simhan, M. Smaldone, K. Tsai, D. Canter, T. Li et al., Objective Measures of Renal Mass Anatomic Complexity Predict Rates of Major Complications Following Partial Nephrectomy, European Urology, vol.60, issue.4, pp.724-754
DOI : 10.1016/j.eururo.2011.05.030

Z. Okhunov, S. Rais-bahrami, A. George, N. Waingankar, B. Duty et al., The Comparison of Three Renal Tumor Scoring Systems: C-Index, P.A.D.U.A., and R.E.N.A.L. Nephrometry Scores, Journal of Endourology, vol.25, issue.12, pp.1921-1925
DOI : 10.1089/end.2011.0301

M. Hew, B. Baseskioglu, K. Barwari, P. Axwijk, C. Can et al., Critical appraisal of the PADUA classification and assessment of the R.E.N.A.L. nephrometry score in patients undergoing partial nephrectomy. The Journal of urology, pp.42-48

D. Galvin, C. Savage, A. Adamy, M. Kaag, O. Brien et al., Intraoperative Conversion From Partial to Radical Nephrectomy at a Single Institution From 2003 to 2008, The Journal of Urology, vol.185, issue.4, pp.1204-1213, 2003.
DOI : 10.1016/j.juro.2010.11.077

F. Porpiglia, A. Volpe, M. Billia, and R. Scarpa, Laparoscopic versus Open Partial Nephrectomy: Analysis of the Current Literature, European Urology, vol.53, issue.4, pp.732-774, 2008.
DOI : 10.1016/j.eururo.2008.01.025

V. Ficarra, S. Bhayani, J. Porter, N. Buffi, R. Lee et al., Predictors of Warm Ischemia Time and Perioperative Complications in a Multicenter, International Series of Robot-Assisted Partial Nephrectomy

G. Godoy, V. Ramanathan, J. Kanofsky, O. Malley, R. Tareen et al., Effect of Warm Ischemia Time During Laparoscopic Partial Nephrectomy on Early Postoperative Glomerular Filtration Rate, The Journal of Urology, vol.181, issue.6, pp.2438-2481, 2009.
DOI : 10.1016/j.juro.2009.02.026

R. Thompson, B. Lane, C. Lohse, B. Leibovich, A. Fergany et al., Every Minute Counts When the Renal Hilum Is Clamped During Partial Nephrectomy, European Urology, vol.58, issue.3, pp.340-345
DOI : 10.1016/j.eururo.2010.05.047

F. Becker, S. Siemer, U. Humke, M. Hack, M. Ziegler et al., Elective Nephron Sparing Surgery Should Become Standard Treatment for Small Unilateral Renal Cell Carcinoma: Long-term Survival Data of 216 Patients, European Urology, vol.49, issue.2, pp.308-321, 2006.
DOI : 10.1016/j.eururo.2005.10.020

F. Marshall, A. Stewart, and H. Menck, The national cancer data base, Cancer, vol.53, issue.11, pp.2167-74, 1997.
DOI : 10.1002/(SICI)1097-0142(19971201)80:11<2167::AID-CNCR18>3.0.CO;2-X

W. Linehan, R. Grubb, J. Coleman, B. Zbar, and M. Walther, The genetic basis of cancer of kidney cancer: implications for gene-specific clinical management, BJU International, vol.170, issue.s2, pp.2-7, 2005.
DOI : 10.1086/376435

M. Patel, R. Simmons, M. Kattan, R. Motzer, V. Reuter et al., Long-term follow-up of bilateral sporadic renal tumors, Urology, vol.61, issue.5, pp.921-926, 2003.
DOI : 10.1016/S0090-4295(02)02578-5

S. Boorjian, P. Crispen, C. Lohse, B. Leibovich, and M. Blute, The Impact of Temporal Presentation on Clinical and Pathological Outcomes for Patients with Sporadic Bilateral Renal Masses, European Urology, vol.54, issue.4, pp.855-63, 2008.
DOI : 10.1016/j.eururo.2008.04.079

G. Grimaldi, V. Reuter, and P. Russo, Bilateral non-familial renal cell carcinoma, Annals of Surgical Oncology, vol.79, issue.6, pp.548-52, 1998.
DOI : 10.1007/BF02303649

M. Hintzy, V. Hupertan, F. Larousserie, Y. Chretien, N. Thiounn et al., Sporadic bilateral kidney tumour: practical approach and place of conservative surgery]. Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie, pp.134-142, 2006.

F. Becker, S. Siemer, A. Tzavaras, H. Suttmann, and M. Stoeckle, Long-term Survival in Bilateral Renal Cell Carcinoma: A Retrospective Single-Institutional Analysis of 101 Patients After Surgical Treatment, Urology, vol.72, issue.2, pp.349-53, 2008.
DOI : 10.1016/j.urology.2008.04.001

H. Zincke and S. Swanson, Bilateral renal cell carcinoma: influence of synchronous and asynchronous occurrence on patient survival, The Journal of urology, vol.128, pp.913-918, 1982.

A. Patel, B. Lee, S. Campbell, M. Zhou, and A. Fergany, Bilateral Synchronous Sporadic Renal Tumors: Pathologic Concordance and Clinical Implications, Urology, vol.78, issue.5, pp.1095-1104
DOI : 10.1016/j.urology.2011.06.051

Y. Neuzillet, E. Lechevallier, M. Andre, L. Daniel, O. Nahon et al., Follow-up of renal oncocytoma diagnosed by percutaneous tumor biopsy, Urology, vol.66, issue.6, pp.1181-1186, 2005.
DOI : 10.1016/j.urology.2005.06.001

D. Kunkle and R. Uzzo, Cryoablation or radiofrequency ablation of the small renal mass, Cancer, vol.68, issue.4 pt 1, pp.2671-80, 2008.
DOI : 10.1002/cncr.23896

T. Klatte, H. Wunderlich, J. Patard, M. Kleid, J. Lam et al., Clinicopathological features and prognosis of synchronous bilateral renal cell carcinoma: an international multicentre experience, BJU International, vol.142, issue.1, pp.21-26, 2007.
DOI : 10.1016/S0022-5347(05)64234-6

T. Klatte, J. Patard, H. Wunderlich, R. Goel, J. Lam et al., Metachronous Bilateral Renal Cell Carcinoma: Risk Assessment, Prognosis and Relevance of the Primary-Free Interval, The Journal of Urology, vol.177, issue.6, pp.2081-2087, 2007.
DOI : 10.1016/j.juro.2007.01.122

J. Patard, A. Pantuck, M. Crepel, J. Lam, L. Bellec et al., Morbidity and Clinical Outcome of Nephron-Sparing Surgery in Relation to Tumour Size and Indication, European Urology, vol.52, issue.1, pp.148-54, 2007.
DOI : 10.1016/j.eururo.2007.01.039

R. De-la-torre, S. Bachman, A. Wheeler, K. Bartow, and J. Scott, Hemostasis and hemostatic agents in minimally invasive surgery, Surgery, vol.142, issue.4, pp.39-45, 2007.
DOI : 10.1016/j.surg.2007.06.023

F. Richter, D. Schnorr, S. Deger, I. Trk, J. Roigas et al., Improvement of hemostasis in open and laparoscopically performed partial nephrectomy using a gelatin matrix-thrombin tissue sealant (FloSeal), Urology, vol.61, issue.1, pp.73-80, 2003.
DOI : 10.1016/S0090-4295(02)02143-X

H. User and R. Nadler, Applications of FloSeal innephron-sparing surgery, Urology, vol.62, issue.2, pp.342-345, 2003.
DOI : 10.1016/S0090-4295(03)00336-4

J. Bak, A. Singh, and B. Shekarriz, Use of Gelatin Matrix Thrombin Tissue Sealant as an Effective Hemostatic Agent During Laparoscopic Partial Nephrectomy, The Journal of Urology, vol.171, issue.2, pp.780-782, 2004.
DOI : 10.1097/01.ju.0000104800.97009.c6

I. Gill, A. Ramani, M. Spaliviero, M. Xu, A. Finelli et al., Improved hemostasis during laparoscopic partial nephrectomy using gelatin matrix thrombin sealant, Urology, vol.65, issue.3, pp.463-469, 2005.
DOI : 10.1016/j.urology.2004.10.030

G. Hidas, A. Kastin, M. Mullerad, J. Shental, B. Moskovitz et al., Sutureless nephron-sparing surgery: Use of albumin glutaraldehyde tissue adhesive (BioGlue), Urology, vol.67, issue.4, pp.697-700, 2006.
DOI : 10.1016/j.urology.2005.10.064

W. Johnston, K. Kelel, B. Hollenbeck, S. Daignault, J. Wolf et al., Acute Integrity of Closure for Partial Nephrectomy: Comparison of 7 Agents in a Hypertensive Porcine Model, The Journal of Urology, vol.175, issue.6, pp.2307-2318, 2006.
DOI : 10.1016/S0022-5347(06)00282-5

R. Nadler, S. Loeb, R. Rubenstein, and I. Vardi, Use of BioGlue in laparoscopic partial nephrectomy, Urology, vol.68, issue.2, pp.416-424, 2006.
DOI : 10.1016/j.urology.2006.02.038

A. Breda, S. Stepanian, J. Lam, J. Liao, I. Gill et al., Use of Haemostatic Agents and Glues during Laparoscopic Partial Nephrectomy: A Multi-Institutional Survey from the United States and Europe of 1347 Cases, European Urology, vol.52, issue.3, pp.798-803, 2007.
DOI : 10.1016/j.eururo.2007.02.035

S. Siemer, S. Lahme, S. Altziebler, S. Machtens, W. Strohmaier et al., Efficacy and Safety of TachoSil?? as Haemostatic Treatment versus Standard Suturing in Kidney Tumour Resection: A Randomised Prospective Study, European Urology, vol.52, issue.4, pp.1156-63, 2007.
DOI : 10.1016/j.eururo.2007.04.027

D. Pick, S. Kolla, P. Mucksavage, M. Louie, P. Sountoulides et al., Sprayed Fibrin Sealant as the Sole Hemostatic Agent for Porcine Laparoscopic Partial Nephrectomy, The Journal of Urology, vol.185, issue.1, pp.291-298, 2011.
DOI : 10.1016/j.juro.2010.09.002

H. Baumert, A. Ballaro, N. Shah, D. Mansouri, N. Zafar et al., Reducing Warm Ischaemia Time During Laparoscopic Partial Nephrectomy: A Prospective Comparison of Two Renal Closure Techniques, European Urology, vol.52, issue.4, pp.1164-1173, 2007.
DOI : 10.1016/j.eururo.2007.03.060

F. Porpiglia, A. Volpe, M. Billia, R. J. Scarpa, and R. , Assessment of Risk Factors for Complications of Laparoscopic Partial Nephrectomy, European Urology, vol.53, issue.3, pp.590-596, 2008.
DOI : 10.1016/j.eururo.2007.10.036

M. Marszalek, M. Carini, P. Chlosta, K. Jeschke, Z. Kirkali et al., Positive Surgical Margins After Nephron-Sparing Surgery, European Urology, vol.61, issue.4, pp.757-63, 2012.
DOI : 10.1016/j.eururo.2011.11.028

S. Sterrett, S. Nakada, M. Wingo, S. Williams, and R. Leveillee, Renal thermal ablative therapy. The Urologic clinics of North America, pp.397-414, 2008.
DOI : 10.1016/j.ucl.2008.05.005

K. Lui, D. Gervais, R. Arellano, and P. Mueller, Radiofrequency Ablation of Renal Cell Carcinoma, Clinical Radiology, vol.58, issue.12, pp.905-918, 2003.
DOI : 10.1016/S0009-9260(03)00222-8

H. Van-poppel, F. Becker, J. Cadeddu, I. Gill, G. Janetschek et al., Treatment of Localised Renal Cell Carcinoma, European Urology, vol.60, issue.4, pp.662-72, 2011.
DOI : 10.1016/j.eururo.2011.06.040

S. Lucas, J. Stern, M. Adibi, I. Zeltser, J. Cadeddu et al., Renal Function Outcomes in Patients Treated for Renal Masses Smaller Than 4 cm by Ablative and Extirpative Techniques, The Journal of Urology, vol.179, issue.1, pp.75-84, 2008.
DOI : 10.1016/j.juro.2007.08.156

R. Hoffmann, T. Jakobs, C. Kubisch, C. Trumm, C. Weber et al., Renal cell carcinoma in patients with a solitary kidney after nephrectomy treated with radiofrequency ablation: Mid term results, European Journal of Radiology, vol.73, issue.3, pp.652-658, 2010.
DOI : 10.1016/j.ejrad.2008.12.015

C. Mitchell, T. Atwell, A. Weisbrod, C. Lohse, S. Boorjian et al., Renal Function Outcomes in Patients Treated With Partial Nephrectomy Versus Percutaneous Ablation for Renal Tumors in a Solitary Kidney, The Journal of Urology, vol.186, issue.5, pp.1786-90, 2011.
DOI : 10.1016/j.juro.2011.07.036

E. Olweny, S. Park, Y. Tan, S. Best, C. Trimmer et al., Radiofrequency Ablation Versus Partial Nephrectomy in Patients with Solitary Clinical T1a Renal Cell Carcinoma: Comparable Oncologic Outcomes at a Minimum of 5 Years of Follow-Up, European Urology, vol.61, issue.6, pp.1156-61, 2012.
DOI : 10.1016/j.eururo.2012.01.001

S. Mylona, A. Kokkinaki, M. Pomoni, P. Galani, S. Ntai et al., Percutaneous radiofrequency ablation of renal cell carcinomas in patients with solitary kidney: 6 years experience, European Journal of Radiology, vol.69, issue.2, pp.351-357, 2009.
DOI : 10.1016/j.ejrad.2007.10.004

T. Atwell, R. Carter, G. Schmit, C. Carr, S. Boorjian et al., Complications following 573 Percutaneous Renal Radiofrequency and Cryoablation Procedures, Journal of Vascular and Interventional Radiology, vol.23, issue.1, pp.48-54, 2012.
DOI : 10.1016/j.jvir.2011.09.008

J. Guillotreau, G. Haber, R. Autorino, R. Miocinovic, S. Hillyer et al., Robotic Partial Nephrectomy Versus Laparoscopic Cryoablation for the Small Renal Mass, European Urology, vol.61, issue.5, pp.899-904, 2012.
DOI : 10.1016/j.eururo.2012.01.007

H. Armah and A. Parwani, Xp11.2 translocation renal cell carcinoma. Archives of pathology & laboratory medicine, pp.124-133, 2010.

A. Lopez-beltran, M. Scarpelli, R. Montironi, and Z. Kirkali, 2004 WHO Classification of the Renal Tumors of the Adults, European Urology, vol.49, issue.5, pp.798-805, 2006.
DOI : 10.1016/j.eururo.2005.11.035

M. Sibony and A. Vieillefond, Les tumeurs du rein qui ne sont pas des carcinomes ?? cellules claires. ??tat des lieux en 2008, Annales de Pathologie, vol.28, issue.5, pp.381-401, 2008.
DOI : 10.1016/j.annpat.2008.07.009

P. Argani, S. Olgac, S. Tickoo, M. Goldfischer, H. Moch et al., Xp11 translocation renal cell carcinoma in adults: expanded clinical, pathologic, and genetic spectrum. The American journal of surgical pathology, pp.1149-60, 2007.

Y. Neuzillet, N. Rioux-leclercq, and B. Escudier, Update on the different histological types of renal cell carcinoma and their specific treatment Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie, pp.23-29, 2011.

A. Lopez-beltran, J. Carrasco, L. Cheng, M. Scarpelli, Z. Kirkali et al., 2009 update on the classification of renal epithelial tumors in adults, International Journal of Urology, vol.32, issue.2, pp.432-475, 2009.
DOI : 10.1111/j.1442-2042.2009.02302.x

H. Armah and A. Parwani, Renal cell carcinoma in a 33-year-old male with an unusual morphology and an aggressive clinical course possible Xp11.2 translocation, Pathology, vol.40, issue.3, pp.306-314, 2008.
DOI : 10.1080/00313020701816373

C. Hung, C. Pan, C. Lin, A. Lin, K. Chen et al., XP11.2 Translocation renal cell carcinoma: Clinical experience of Taipei Veterans General Hospital, Journal of the Chinese Medical Association, vol.74, issue.11, pp.500-504, 2011.
DOI : 10.1016/j.jcma.2011.09.005

Y. Komai, M. Fujiwara, Y. Fujii, H. Mukai, J. Yonese et al., Adult Xp11 translocation renal cell carcinoma diagnosed by cytogenetics and immunohistochemistry. Clinical cancer research : an official journal of the American Association for Cancer Research, pp.1170-1176, 2009.

C. Lagrange, S. Lele, and S. Strup, Renal Cell Carcinoma Associated with TFE3 Gene Fusion in an Elderly Woman, Urology, vol.70, issue.3, pp.590-601, 2007.
DOI : 10.1016/j.urology.2007.06.1096

P. Camparo, V. Vasiliu, V. Molinie, J. Couturier, K. Dykema et al., Renal Translocation Carcinomas, The American Journal of Surgical Pathology, vol.32, issue.5, pp.656-70, 2008.
DOI : 10.1097/PAS.0b013e3181609914

M. Hintzy, P. Camparo, V. Vasiliu, M. Peyromaure, and A. Vieillefond, Renal carcinoma associated with MiTF/TFE translocation: report of six cases in young adults]. Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie, pp.275-80, 2008.

S. Suzigan, R. Drut, P. Faria, P. Argani, D. Marzo et al., Xp11 Translocation Carcinoma of the Kidney Presenting With Multilocular Cystic Renal Cell Carcinoma-Like Features, International Journal of Surgical Pathology, vol.15, issue.2, pp.199-203, 2007.
DOI : 10.1177/1066896906295891

G. Malouf, P. Camparo, S. Oudard, G. Schleiermacher, C. Theodore et al., Targeted agents in metastatic Xp11 translocation/TFE3 gene fusion renal cell carcinoma (RCC): a report from the Juvenile RCC Network, Annals of Oncology, vol.21, issue.9, pp.1834-1842, 2010.
DOI : 10.1093/annonc/mdq029

T. Choueiri, Z. Lim, M. Hirsch, P. Tamboli, E. Jonasch et al., Vascular endothelial growth factor-targeted therapy for the treatment of adult metastatic Xp11

T. Choueiri, J. Mosquera, and M. Hirsch, A Case of Adult Metastatic Xp11 Translocation Renal Cell Carcinoma Treated Successfully With Sunitinib, Clinical Genitourinary Cancer, vol.7, issue.3, pp.93-97, 2009.
DOI : 10.3816/CGC.2009.n.031

R. Qiu, G. Bing, and X. Zhou, Xp11.2 Translocation renal cell carcinomas have a poorer prognosis than non-Xp11.2 translocation carcinomas in children and young adults: a metaanalysis, International journal of surgical pathology, vol.18, pp.458-64, 2010.